Cargando…
Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease
Background: Human olfactory mesenchymal stem cells (OMSC) have become a novel therapeutic option for immune disorder or demyelinating disease due to their immunomodulatory and regenerative potentials. However, the immunomodulatory effects of OMSC still need to be elucidated, and comparisons of the e...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702423/ https://www.ncbi.nlm.nih.gov/pubmed/34955841 http://dx.doi.org/10.3389/fphar.2021.770884 |
_version_ | 1784621245400088576 |
---|---|
author | Xiao, Chongjun Lu, Di Chen, Jinshuo Chen, Xiaoyan Lin, Huizhu Huang, Mudan Cheng, Shimei Wang, Yuge Liu, Qiuli Zheng, Haiqing |
author_facet | Xiao, Chongjun Lu, Di Chen, Jinshuo Chen, Xiaoyan Lin, Huizhu Huang, Mudan Cheng, Shimei Wang, Yuge Liu, Qiuli Zheng, Haiqing |
author_sort | Xiao, Chongjun |
collection | PubMed |
description | Background: Human olfactory mesenchymal stem cells (OMSC) have become a novel therapeutic option for immune disorder or demyelinating disease due to their immunomodulatory and regenerative potentials. However, the immunomodulatory effects of OMSC still need to be elucidated, and comparisons of the effects of different MSCs are also required in order to select an optimal cell source for further applications. Results: In animal experiments, we found neural functional recovery and delayed EAE attack in the OMSC treatment group. Compared with umbilical cord–derived mesenchymal stem cells (UMSC) treatment group and the control group, the OMSC treatment group had a better neurological improvement, lower serum levels of IFN-γ, and a lower proportion of CD4+IFN-γ+ T splenic lymphocyte. We also observed OMSC effectively suppressed CD4+IFN-γ+ T cell proportion in vitro when co-cultured with human peripheral blood–derived lymphocytes. The OMSC-mediated immunosuppressive effect on human CD4+IFN-γ+ T cells was attenuated by blocking cyclooxygenase activity. Conclusion: Our results suggest that OMSC treatment delayed the onset and promoted the neural functional recovery in the EAE mouse model possibly by suppressing CD4+IFN-γ+ T cells. OMSC transplantation might become an alternative therapeutic option for neurological autoimmune disease. |
format | Online Article Text |
id | pubmed-8702423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87024232021-12-25 Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease Xiao, Chongjun Lu, Di Chen, Jinshuo Chen, Xiaoyan Lin, Huizhu Huang, Mudan Cheng, Shimei Wang, Yuge Liu, Qiuli Zheng, Haiqing Front Pharmacol Pharmacology Background: Human olfactory mesenchymal stem cells (OMSC) have become a novel therapeutic option for immune disorder or demyelinating disease due to their immunomodulatory and regenerative potentials. However, the immunomodulatory effects of OMSC still need to be elucidated, and comparisons of the effects of different MSCs are also required in order to select an optimal cell source for further applications. Results: In animal experiments, we found neural functional recovery and delayed EAE attack in the OMSC treatment group. Compared with umbilical cord–derived mesenchymal stem cells (UMSC) treatment group and the control group, the OMSC treatment group had a better neurological improvement, lower serum levels of IFN-γ, and a lower proportion of CD4+IFN-γ+ T splenic lymphocyte. We also observed OMSC effectively suppressed CD4+IFN-γ+ T cell proportion in vitro when co-cultured with human peripheral blood–derived lymphocytes. The OMSC-mediated immunosuppressive effect on human CD4+IFN-γ+ T cells was attenuated by blocking cyclooxygenase activity. Conclusion: Our results suggest that OMSC treatment delayed the onset and promoted the neural functional recovery in the EAE mouse model possibly by suppressing CD4+IFN-γ+ T cells. OMSC transplantation might become an alternative therapeutic option for neurological autoimmune disease. Frontiers Media S.A. 2021-12-10 /pmc/articles/PMC8702423/ /pubmed/34955841 http://dx.doi.org/10.3389/fphar.2021.770884 Text en Copyright © 2021 Xiao, Lu, Chen, Chen, Lin, Huang, Cheng, Wang, Liu and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Xiao, Chongjun Lu, Di Chen, Jinshuo Chen, Xiaoyan Lin, Huizhu Huang, Mudan Cheng, Shimei Wang, Yuge Liu, Qiuli Zheng, Haiqing Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease |
title | Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease |
title_full | Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease |
title_fullStr | Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease |
title_full_unstemmed | Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease |
title_short | Human Olfactory Mesenchymal Stem Cells Are a Novel Candidate for Neurological Autoimmune Disease |
title_sort | human olfactory mesenchymal stem cells are a novel candidate for neurological autoimmune disease |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702423/ https://www.ncbi.nlm.nih.gov/pubmed/34955841 http://dx.doi.org/10.3389/fphar.2021.770884 |
work_keys_str_mv | AT xiaochongjun humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT ludi humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT chenjinshuo humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT chenxiaoyan humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT linhuizhu humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT huangmudan humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT chengshimei humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT wangyuge humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT liuqiuli humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease AT zhenghaiqing humanolfactorymesenchymalstemcellsareanovelcandidateforneurologicalautoimmunedisease |